Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbra A Dickerman

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
The Journal of Urology|April 21, 2018
Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate CancerPhilipp Gild, Alexander P Cole, Anna Krasnova, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2021
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular SubtypesXiaoshuang Feng, Cindy Ke Zhou, Clary B Clish, et al.
Journal of the National Cancer Institute|September 15, 2023
Prostate cancer screening in African American men: a review of the evidenceKevin H Kensler, Roman Johnson, Faith Morley, et al.
BMJ Open|September 12, 2023
Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guidelineHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
Nature Medicine|April 27, 2026
The TARGET guideline for reporting observational studies of interventionsHarrison J Hansford, James H McAuley, Sonja A Swanson, et al.
JAMA|September 3, 2025
Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
BMJ (Clinical Research Ed.)|September 3, 2025
Transparent reporting of observational studies emulating a target trial: the TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
Cancer Medicine|June 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal TimeXabier Garcia-Albeniz, Julia Vila-Guilera, Manuel Zamparini, et al.
JAMA Network Open|September 27, 2023
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic ReviewHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The Journal of Urology|April 21, 2018
Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate CancerPhilipp Gild, Alexander P Cole, Anna Krasnova, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2021
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular SubtypesXiaoshuang Feng, Cindy Ke Zhou, Clary B Clish, et al.
Journal of the National Cancer Institute|September 15, 2023
Prostate cancer screening in African American men: a review of the evidenceKevin H Kensler, Roman Johnson, Faith Morley, et al.
BMJ Open|September 12, 2023
Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guidelineHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
Nature Medicine|April 27, 2026
The TARGET guideline for reporting observational studies of interventionsHarrison J Hansford, James H McAuley, Sonja A Swanson, et al.
JAMA|September 3, 2025
Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
BMJ (Clinical Research Ed.)|September 3, 2025
Transparent reporting of observational studies emulating a target trial: the TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
Cancer Medicine|June 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal TimeXabier Garcia-Albeniz, Julia Vila-Guilera, Manuel Zamparini, et al.
JAMA Network Open|September 27, 2023
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic ReviewHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
Pageof 5